Improving Global Vascular Risk Prediction With Behavioral and Anthropometric Factors. The Multiethnic NOMAS (Northern Manhattan Cohort Study)

Journal of the American College of Cardiology

Volumn 54, Issue 24, 2009, Pages 2303-2311

  Sacco, Ralph L ^a   Khatri, Minesh ^b   Rundek, Tatjana ^a   Xu, Qiang ^b   Gardener, Hannah ^a   Boden Albala, Bernadette ^b   Di Tullio, Marco R ^b   Homma, Shunichi ^b   Elkind, Mitchell S V ^b   Paik, Myunghee C ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

cardiovascular disease; cerebrovascular disease; epidemiology; prevention; risk factors

Indexed keywords

ADULT; AFRICAN AMERICAN; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; BEHAVIOR; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIET RESTRICTION; ETHNICITY; EUROPEAN AMERICAN; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HISPANIC; HUMAN; HYPERTENSION; MALE; NORMAL HUMAN; PHYSICAL ACTIVITY; PREDICTION; PRIMARY PREVENTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; STROKE; WAIST CIRCUMFERENCE;

AGED; ANTHROPOMETRY; BEHAVIOR; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MODELS, STATISTICAL; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 70549113081     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.07.047     Document Type: Article

References (41)

1. Goldstein L.B., Adams R., Alberts M.J., et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke 37 (2006) 1583-1633
2. Ridker P.M., Buring J.E., Rifai N., and Cook N.R. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 297 (2007) 611-619
3. Assmann G., Cullen P., and Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study. Circulation 105 (2002) 310-315
4. Tanne D., Yaari S., and Goldbourt U. Risk profile and prediction of long-term ischemic stroke mortality: a 21-year follow-up in the Israeli Ischemic Heart Disease (IIHD) project. Circulation 98 (1998) 1365-1371
5. D'Agostino R.B., Wolf P.A., Belanger A.J., and Kannel W.B. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke 25 (1994) 40-43
6. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
7. Chambless L.E., Folsom A.R., Sharrett A.R., et al. Coronary heart disease risk prediction in the atherosclerosis risk in communities (ARIC) study. J Clin Epidemiol 56 (2003) 880-890
8. Chambless L.E., Heiss G., Shahar E., Earp M.J., and Toole J. Prediction of ischemic stroke risk in the Atherosclerosis Risk In Communities study. Am J Epidemiol 160 (2004) 259-269
9. Lumley T., Kronmal R.A., Cushman M., Manolio T.A., and Goldstein S. A stroke prediction score in the elderly: Validation and web-based application. J Clin Epidemiol 55 (2002) 129-136
10. D'Agostino R.B., Vasan R.S., Pencina M.J., et al. General cardiovascular risk profile for use in a primary care-the Framingham Heart Study. Circulation 117 (2008) 743-753
11. D'Agostino Sr. R.B., Grundy S., Sullivan L.M., and Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286 (2001) 180-187
12. de Visser C.L., Bilo H.J., Thomsen T.F., Groenier K.H., and Meyboom-de Jong B. Prediction of coronary heart disease: a comparison between the Copenhagen risk score and the Framingham risk score applied to a Dutch population. J Intern Med 253 (2003) 553-562
13. Diverse Populations Collaboration Group. Prediction of mortality from coronary heart disease among diverse populations: is there a common predictive function?. Heart 88 (2002) 222-228
14. Thomsen T.F., McGee D., Davidsen M., and Jorgensen T. A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup population studies and Framingham Heart Study. Int J Epidemiol 31 (2002) 817-822
15. Menotti A., Puddu P.E., and Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J 21 (2000) 365-370
16. Sacco R.L., Anand K., Lee H.S., et al. Homocysteine and the risk of ischemic stroke in a triethnic cohort: the Northern Manhattan Study. Stroke 35 (2004) 2263-2269
17. Moss A.J., and Parsons V.L. Current estimates from the national health interview survey. United States, 1985. Vital Health Stat 10 i-iv (1986 Sep) 1-182
18. Echt D.S., Liebson P.R., Mitchell L.B., et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression trial. N Engl J Med 324 (1991) 781-788
19. Schaefer E.J., Lamon-Fava S., Jenner J.L., et al. Lipoprotein(a) levels and risk of coronary heart disease in men. The Lipid Research Clinics Coronary Primary Prevention trial. JAMA 271 (1994) 999-1003
20. Cleveland W.S. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 74 (1979) 829-836
21. McCullagh P., and Nelder J. Generalized Linear Models (1989), Chapman and Hall, London
22. Akaike H. A new look at the statistical model identification. IEEE Trans Automatic Control 19 (1974) 716-723
23. Cook N. Use and misuse of the ROC curve in risk prediction. Circulation 115 (2007) 928-935
24. Pencina M.J., D'Agostino Sr. R.B., D'Agostino Jr. R.B., and Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27 (2008) 157-172
25. Pepe M.S., Feng Z., and Gu J.W. Comments on 'Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond' by M. J. Pencina et al. Stat Med 27 (2008) 173-181
26. Global Vascular Risk Score Calculator. http://neurology.med.miami.edu/gvr/gvr.htm Accessed October 16, 2009
27. Pocock S.J., McCormack V., Gueyffier F., Boutitie F., Fagard R.H., and Boissel J.P. A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. BMJ 323 (2001) 75-81
28. Houston M.C., Basile J., Bestermann W.H., et al. Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern united states. Am J Med Sci 329 (2005) 276-291
29. Clayton T.C., Lubsen J., Pocock S.J., et al. Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patients. BMJ 331 (2005) 869
30. Hippisley-Cox J., Coupland C., Vinogradova Y., Robson J., May M., and Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: a prospective open cohort study. BMJ 335 (2007) 136-147
31. Folsom A.R., Chambless L.E., Ballantyne C.M., et al. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the Atherosclerosis Risk In Communities study. Arch Intern Med 166 (2006) 1368-1373
32. Wang T.J., Gona P., Larson M.G., et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 355 (2006) 2631-2639
33. Greenland P., and Lloyd-Jones D. Defining a rational approach to screening for cardiovascular risk in asymptomatic patients. J Am Coll Cardiol 52 (2008) 330-332
34. Wilson P.W., Bozeman S.R., Burton T.M., Hoaglin D.C., Ben-Joseph R., and Pashos C.L. Prediction of first events of coronary heart disease and stroke with consideration of adiposity. Circulation 118 (2008) 124-130
35. Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 346 (1995) 1647-1653
36. Corti M.C., Guralnik J.M., Salive M.E., et al. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med 126 (1997) 753-760
37. Krumholz H.M., Seeman T.E., Merrill S.S., et al. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA 272 (1994) 1335-1340
38. Gaziano T.A., Young C.R., Fitzmaurice G., Atwood S., and Gaziano J.M. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-Up Study cohort. Lancet 371 (2008) 923-931
39. Gelber R.P., Gaziano J.M., Orav E.J., Manson J.E., Buring J.E., and Kurth T. Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol 52 (2008) 605-615
40. Franklin S.S., Lopez V.A., Wong N.D., et al. Single versus combined blood pressure components and risk for cardiovascular disease: the Framingham Heart Study. Circulation 119 (2009) 243-250
41. Califf R.M., Armstrong P.W., Carver J.R., D'Agostino R.B., and Strauss W.E. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. J Am Coll Cardiol 27 (1996) 1007-1019